Showing results (31-40 of 643) with videos related to

Sort By:
Pageof 65
Biomarkers in Medicine|April 3, 2010
Cerebrospinal fluid biomarkers of Alzheimer's diseaseAnne M Fagan, David M Holtzman
Neuron|July 26, 2005
The bad seed in Alzheimer's diseaseJohn D Fryer, David M Holtzman
Neuron|December 24, 2013
Biomarker modeling of Alzheimer's diseaseClifford R Jack, David M Holtzman
The Journal of Experimental Medicine|April 25, 2018
Dual therapy for Aβ amyloidosis in AD: A successful one-two comboTirth K Patel, David M Holtzman
Nature Neuroscience|May 27, 2015
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'Erik S Musiek, David M Holtzman
The Journal of Clinical Investigation|August 5, 2003
Amyloid beta and Alzheimer disease therapeutics: the devil may be in the detailsJohn R Cirrito, David M Holtzman
ACS Chemical Neuroscience|February 9, 2016
TREM2 Function in Alzheimer's Disease and NeurodegenerationJason D Ulrich, David M Holtzman
Cell|October 1, 2019
Alzheimer Disease: An Update on Pathobiology and Treatment StrategiesJustin M Long, David M Holtzman
Current Opinion in Neurology|October 9, 2012
Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvementErik S Musiek, David M Holtzman
Nature Medicine|September 4, 2023
Emerging diagnostics and therapeutics for Alzheimer diseaseWade K Self, David M Holtzman
Pageof 65